presented, and in 2016 it was assigned its own ICD-10 code (1, 3, 5, 6, 8, 9, 11) . A comparison of the 50 original definition with the new consensus definitions clarifies how the term Sarcopenia no longer describes 51 the phenomenon it originally addressed. Rather, the term is now caught in tautological association, which 52 causes confusion and hinders rather than helps understanding of this condition. 53
The original definition 54
In 1989, Rosenberg observed that the phenomenon of decreasing lean body mass with older age had not been 55
given the scientific attention it deserved, and drew attention to it, in suggesting a name combining the two 56 words sarco (meaning flesh) and penia (meaning loss), in accordance with the characteristic that it 57 described(10). The focus of this original definition was the loss of muscle mass as a discrete phenomenon, 58 with a leading interest in legitimizing clinical and scientific attention to it(10). This definition of Sarcopenia 59 was used descriptively with the purpose of defining and articulating the loss of skeletal muscle mass, as a 60 concrete object. 61
The new consensus definitions 62
Between 2011 and 2014, six consensus definitions of Sarcopenia were agreed (3, 5, 6, 8, 9, 11) . These 63 shifted the focus from the original phenomenon of loss of skeletal muscle mass to that of physical function. 64
All of these definitions employ an algorithm with the same logic. Physical function capability is initially 65 assessed (gait speed or grip strength), and only if function is impaired below a cut-point, is muscle mass (as 66 the appendicular lean mass (ALM)) secondarily evaluated. Hence, low muscle mass is not a single stand-67 alone determinant by which Sarcopenia is defined, and having only a low muscle mass is not an adequate 68 criterion by which to be defined as being Sarcopenic. Physical function is not synonymous with muscle 69 function although the concepts are sometimes used interchangeable in the six consensus articles. Physical 70 function is an interplay between multiple organ systems that can be estimated through tests like gaitspeed 71 whereas skeletal muscle, besides having the capability of contracting and allowing movement, has many 72 functions in metabolism and as an endocrine organ. 73
The consensus definitions were made by working groups, with representatives from different Societies 74 within the geriatric field, in Europe, the United States and Asia, two of them receiving partial funding from 75 the pharmaceutical industry. Discussion surrounding these definitions focusses most strongly on 76 determination of the exact cut-off values for both physical function tests and muscle mass measurements. 77 Surprisingly, the theoretical framework underpinning the definitions is not discussed thoroughly in any of the 78 articles and arguments for the inclusion of physical function is found in only three(5, 8, 11) of the six 79 papers. They share one main argument only, that the original definition is not clinically relevant. as gait speed have stronger association than low muscle mass to a decrease in physical function and 94 mortality. Instead of concentrating on the loss of muscle mass, research interest centered on the robustness ofFrom a clinical perspective it appears reasonable to focus on the phenomenon with the strongest association 99 to a negative health outcome. However, in this case the outcome and the phenomenon is almost, if not 100 exactly, identical, and the argument for the change of focus from muscle mass to physical function is a 101 tautology -arguing that there should be a change in focus from decreased muscle mass to decreased physical 102 function, since a decrease in physical function has a stronger association with a decrease in physical 103
function. 104 105
There are several consequences of the change in definition. According to the algorithms used in the 106 consensus definitions, skeletal muscle is only of value to the definitions if it is associated with bodily 107 movement. If gait speed is not reduced, presence of a low muscle mass is irrelevant according to the 108 consensus definitions. This is despite the fact that skeletal muscle is the largest metabolic organ of the body, 109
and is crucial in the endocrine regulation of metabolism as well as being the body's largest reservoir of 110 amino acids(7). Such functions are likely to be overlooked clinically when the primary inclusion criterion for 111 sarcopenia is physical function and not muscle mass. Likewise, physical function is at risk of being reduced 112 to the question of muscle mass when both are directly coupled in the definition(4). Further, it reduces the 113 relevance of the term in other clinical specialties such as nephrology and endocrinology, where muscle mass 114 per se could be of clinical importance for both categorizing patients as well as in selecting treatment. Beside 115 the reductionist understanding of the two different phenomena, the new definitions also lead to general 116 confusion of what is meant by the term Sarcopenia, since it no longer covers one but two phenomena. 117 unambiguous and useful term. Perhaps returning to the original definition could cause confusion in relation 125 to acceptance of age related loss of muscle mass as a clinical relevant phenomenon. However, the theoretical 126 foundations of the consensus definitions are tautological, and we anticipate that the consequences of these 127 definitions would continue to create confusion. There may be other and better definitions than the original 128 but since nobody will benefit from the current consensus definitions, breaking out of the tautology is 129 necessary to allow science and clinical practice to move on. 130
